Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-31

FDA Approved: MYTESI — Original Application (Napo Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for MYTESI (crofelemer) by Napo Pharmaceuticals for relief of non-infectious diarrhea in adults with HIV/AIDS on antiretro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mytesi (crofelemer)

Snippet

ORIG AP for MYTESI (CROFELEMER)